Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.49B |
| 2 |
Cloudflare
NET
|
+$1.3B |
| 3 |
Roblox
RBLX
|
+$1.1B |
| 4 |
Wayfair
W
|
+$1.05B |
| 5 |
Microsoft
MSFT
|
+$708M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.83B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.24B |
| 3 |
Amazon
AMZN
|
+$1.48B |
| 4 |
Intuitive Surgical
ISRG
|
+$1.39B |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.1% |
| 2 | Healthcare | 9.79% |
| 3 | Consumer Discretionary | 9.12% |
| 4 | Communication Services | 9.08% |
| 5 | Financials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5701
Innovator US Equity Ultra Buffer ETF October
UOCT
$181M
| $277K | ﹤0.01% |
10,000
| – | – |
|
5702
Pulmatrix
PULM
$5.51M
| $276K | ﹤0.01% |
13,272
+12,474
| +1,563% | +$253K |
|
|
BXRX
5703
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
| $276K | ﹤0.01% |
259
+257
| +12,850% | +$336K |
|
5704
OP Bancorp
OPBK
$235M
| $275K | ﹤0.01% |
27,316
-67
| -0.2% | -$701 |
|
5705
Cyclerion Therapeutics
CYCN
$18.3M
| $274K | ﹤0.01% |
3,508
+1,619
| +86% | +$101K |
|
5706
Innoviz Technologies
INVZ
$114M
| $274K | ﹤0.01% |
+25,979
| New | +$270K |
|
|
FRLN
5707
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $274K | ﹤0.01% |
2,242
+754
| +51% | +$117K |
|
|
CHMA
5708
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $274K | ﹤0.01% |
58,107
-164,149
| -74% | -$618K |
|
5709
Duluth Holdings
DLTH
$151M
| $273K | ﹤0.01% |
13,171
+7,359
| +127% | +$121K |
|
5710
Zevra Therapeutics
ZVRA
$664M
| $272K | ﹤0.01% |
21,234
+11,141
| +110% | +$120K |
|
|
SMIT
5711
DELISTED
Schmitt Industries Inc
SMIT
| $272K | ﹤0.01% |
49,520
+3,500
| +8% | +$20.9K |
|
|
KLDO
5712
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $272K | ﹤0.01% |
36,526
+16,864
| +86% | +$120K |
|
|
GGM
5713
DELISTED
GUGGENHEIM CREDIT ALLOCATION FUND
GGM
| $272K | ﹤0.01% |
12,425
-240
| -2% | -$5.07K |
|
5714
iShares MSCI Finland ETF
EFNL
$254M
| $271K | ﹤0.01% |
5,484
-414
| -7% | -$20.4K |
|
5715
Timberland Bancorp
TSBK
$361M
| $271K | ﹤0.01% |
9,622
-714
| -7% | -$20.3K |
|
5716
Carter Bankshares
CARE
$757M
| $269K | ﹤0.01% |
21,553
+15,996
| +288% | +$224K |
|
|
TRML
5717
DELISTED
Tourmaline Bio
TRML
| $269K | ﹤0.01% |
+1,825
| New | +$280K |
|
|
TTSH
5718
DELISTED
Tile Shop Holdings
TTSH
| $269K | ﹤0.01% |
+33,450
| New | +$280K |
|
5719
FRP Holdings
FRPH
$425M
| $267K | ﹤0.01% |
9,566
+8,142
| +572% | +$225K |
|
|
SEMR
5720
DELISTED
Semrush
SEMR
| $267K | ﹤0.01% |
+11,613
| New | +$202K |
|
5721
Aveanna Healthcare
AVAH
$2.46B
| $266K | ﹤0.01% |
+21,531
| New | +$255K |
|
|
ATXS
5722
DELISTED
Astria Therapeutics
ATXS
| $265K | ﹤0.01% |
20,991
+3,344
| +19% | +$43.4K |
|
|
AMOV
5723
DELISTED
America Movil SAB de CV
AMOV
| $263K | ﹤0.01% |
17,517
-2,062
| -11% | -$30.5K |
|
|
MXF
5724
Mexico Fund
MXF
$309M
| $262K | ﹤0.01% |
17,220
-7,902
| -31% | -$119K |
|
5725
Grindr
GRND
$2.74B
| $261K | ﹤0.01% |
26,070
-4,300
| -14% | -$43.3K |
|
Similar funds
Morgan Stanley's Q2 2021 Portfolio in Review
As of Q2 2021, Morgan Stanley held 8,036 positions worth $758B, up 11% from $681B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley deployed $26.3B of net new capital in Q2 2021, opening 455 new positions and adding to 4,497 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 49,152,168 shares worth $695M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $6.83B trimmed.
- Morgan Stanley's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 49,152,168 shares worth $695M.
- Morgan Stanley added most to Vanguard Total Bond Market in Q2 2021, an estimated $1.49B increase.
- Morgan Stanley's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.83B.
- Morgan Stanley fully exited RealPage, Inc. in Q2 2021, selling an estimated $193M.
- Morgan Stanley's ten largest holdings make up 15% of its $758B portfolio in Q2 2021.
- Morgan Stanley opened 455 new positions and closed 221 in Q2 2021.
- Morgan Stanley's portfolio value rose 11% quarter-over-quarter to $758B.
Based on Morgan Stanley's 13F filing for Q2 2021, filed 16 Aug 2021.